EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NTRK gene fusion testing and management in lung cancer

Matteo Repetto, Marina Chiara Garassino, Herbert H Loong, Fernando Lopez-Rios, Tony Mok, Solange Peters, David Planchard, Sanjay Popat, Erin R Rudzinski, Alexander Drilon, Caicun Zhou

Cancer Treatment Reviews · 2024

DOI: 10.1016/j.ctrv.2024.102733 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2024. Verfasst von Matteo Repetto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address: repettom@mskcc.org. Hauptthemen laut MEDLINE: Lung Neoplasms, Receptor, trkA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer HealthCare Pharmaceuticals Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsReceptor, trkAHumansGene FusionCarcinoma, Non-Small-Cell LungOncogene Proteins, FusionHigh-Throughput Nucleotide SequencingProtein Kinase InhibitorsReceptor, trkB

Stichwörter der Autor:innen

Lung cancerNTRK gene fusionTRK fusion

Substanzen

Receptor, trkAOncogene Proteins, FusionProtein Kinase InhibitorsReceptor, trkBNTRK1 protein, human

Autor:innen und Institutionen

  • Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address: repettom@mskcc.org.
  • Department of Medicine, Thoracic Oncology Program, The University of Chicago, Chicago, IL, USA.
  • The Chinese University of Hong Kong, Hong Kong, China.
  • Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland.
  • Gustave Roussy, Villejuif, France.

Förderung

  • Bayer HealthCare Pharmaceuticals Inc

Zitieren

APA

Repetto, M., Chiara Garassino, M., Loong, H. H., Lopez-Rios, F., Mok, T., Peters, S., Planchard, D., Popat, S., Rudzinski, E. R., Drilon, A., & Zhou, C. (2024). NTRK gene fusion testing and management in lung cancer. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2024.102733

Vancouver

Repetto M, Chiara Garassino M, Loong HH, Lopez-Rios F, Mok T, Peters S, et al. NTRK gene fusion testing and management in lung cancer. Cancer Treatment Reviews. 2024. doi:10.1016/j.ctrv.2024.102733

BibTeX
@article{Repetto2024,
  author = {Repetto, Matteo and Chiara Garassino, Marina and Loong, Herbert H and Lopez-Rios, Fernando and Mok, Tony and Peters, Solange and Planchard, David and Popat, Sanjay and Rudzinski, Erin R and Drilon, Alexander and Zhou, Caicun},
  title = {NTRK gene fusion testing and management in lung cancer},
  journal = {Cancer Treatment Reviews},
  year = {2024},
  doi = {10.1016/j.ctrv.2024.102733}
}
Kostenlos starten →